Gestational Trophoblastic Tumor Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Condition: Gestational Trophoblastic Neoplasias (GTN) Interventions: Drug: Avelumab Injection; Drug: Methotrexate 1 GM Injection Sponsors: Hospices Civils de Lyon; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 20, 2020 Category: Research Source Type: clinical trials
